Geneva, Switzerland

Francesca Gaggini

USPTO Granted Patents = 12 


 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • Geneva, FR (2014)
  • Geneva, CH (2013 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Francesca Gaggini: Innovator in Pharmaceutical Chemistry

Introduction

Francesca Gaggini is a prominent inventor based in Geneva, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. With a total of 12 patents to her name, Gaggini's work focuses on addressing critical health issues through her inventions.

Latest Patents

One of her latest patents involves pyrazolo pyridine derivatives as NADPH oxidase inhibitors. This invention relates to pyrazolo pyridine derivatives of Formula (I), along with pharmaceutical compositions and their applications for the treatment and/or prophylaxis of disorders associated with Nicotinamide adenine dinucleotide phosphate oxidase (NADPH Oxidase). This groundbreaking work has the potential to impact various medical conditions significantly.

Career Highlights

Throughout her career, Francesca Gaggini has worked with notable companies, including Genkyotex SA and Genkyotex Suisse SA. Her expertise in pharmaceutical chemistry has allowed her to develop innovative solutions that address complex health challenges.

Collaborations

Francesca has collaborated with esteemed colleagues such as Patrick Naxos Page and Mike Orchard. These partnerships have further enhanced her research and development efforts in the pharmaceutical field.

Conclusion

Francesca Gaggini's contributions to pharmaceutical chemistry through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…